Your browser doesn't support javascript.
loading
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH).
Flaherty, Keith T; Gray, Robert J; Chen, Alice P; Li, Shuli; McShane, Lisa M; Patton, David; Hamilton, Stanley R; Williams, P Mickey; Iafrate, A John; Sklar, Jeffrey; Mitchell, Edith P; Harris, Lyndsay N; Takebe, Naoko; Sims, David J; Coffey, Brent; Fu, Tony; Routbort, Mark; Zwiebel, James A; Rubinstein, Larry V; Little, Richard F; Arteaga, Carlos L; Comis, Robert; Abrams, Jeffrey S; O'Dwyer, Peter J; Conley, Barbara A.
Afiliación
  • Flaherty KT; Massachusetts General Hospital, Boston, MA.
  • Gray RJ; ECOG-ACRIN Cancer Research Group Biostatistics Center, Dana Farber Cancer Institute Boston, MA.
  • Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.
  • Li S; ECOG-ACRIN Cancer Research Group Biostatistics Center, Dana Farber Cancer Institute Boston, MA.
  • McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.
  • Patton D; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD.
  • Hamilton SR; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Iafrate AJ; Massachusetts General Hospital, Boston, MA.
  • Sklar J; Harvard University, Boston, MA.
  • Mitchell EP; Yale University, New Haven, CT.
  • Harris LN; Thomas Jefferson University Hospital, Philadelphia, PA.
  • Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.
  • Sims DJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.
  • Coffey B; Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Fu T; Center for Biomedical Informatics and Information Technology, Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Routbort M; Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Zwiebel JA; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.
  • Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.
  • Arteaga CL; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.
  • Comis R; University of Texas Southwestern Simmons Cancer Center, Dallas, TX.
  • Abrams JS; ECOG-ACRIN Cancer Research Group, Philadelphia, PA.
  • O'Dwyer PJ; Deceased.
  • Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.
J Clin Oncol ; 38(33): 3883-3894, 2020 11 20.
Article en En | MEDLINE | ID: mdl-33048619
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Guideline Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Guideline Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Estados Unidos